Phosphorylated c-Src in the nucleus is associated with improved patient outcome in ER-positive breast cancer

Tamoxifen for early breast cancer: an overview of the randomised trials

The Lancet · 1998 · 4.1K citations

Breast Oncology, Early Breast Cancer, Medicine +10

Polychemotherapy for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

C. Focan, S. M. Steinberg, M Blichert-Toft et al. · PubMed · 1998 · 2.2K citations

Tamoxifen for early breast cancer: an overview of the randomised trials. Early Breast Cancer Trialists' Collaborative Group.

PubMed · 1998 · 903 citations

Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.

McCarty Ks, Éva Szabó, Flowers Jl et al. · PubMed · 1986 · 422 citations

Human Tumors, Tumor Biology, Breast Oncology +15

Dasatinib, an orally active small molecule inhibitor of both the src and abl kinases, selectively inhibits growth of basal-type/“triple-negative” breast cancer cell lines growing in vitro

Richard S. Finn, Judy Dering, Charles Ginther et al. · Breast Cancer Research and Treatment · 2007 · 400 citations · Full text

Breast Oncology, Pathology, Cancer Biology +17